DSRM-3716

N/A

Report date: 2023/01/08 14:04:03
NME

Base Information

Drug NameDSRM-3716
Drug Alias NameDSRM-3716
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD(+) hydrolase SARM1 inhibitors
TargetsNAD(+) hydrolase SARM1
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDisarm Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesDisarm Therapeutics
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A